Study of changes in biochemical parameters of preeclampsia patients, a prospective five year study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20220181Keywords:
Biochemical parameters, HOMA IR, PreeclampsiaAbstract
Background: Preeclampsia is associated with changes in biochemical parameters like hepatic dysfunction, increase in blood glucose, thrombocytopenia, urea, creatinine, uric acid, alteration in lipid profile, hypoalbuminemia, electrolyte and C-reactive protein. Based on variability in literature regarding biochemical parameters present study has been designed to evaluate the changes in biochemical parameters in preeclampsia patients in tertiary care hospital.
Methods: Pregnant women with pre eclampsia attending OPD of obstetrics department were enrolled for this study based on following inclusion and exclusion criteria. Similarly normotensive pregnant women were enrolled as control per same inclusion and exclusion criteria.
Results: Total platelet count was significantly lower in preeclampsia patients then control (2.02±0.7 lakh/µl versus 3.29±.58 lakh/µl). Blood urea was significantly higher in preeclampsia patients than control (29.22±4.56 mg/dl versus 18.32±6.23 mg/dl), (p=0.0001) serum uric acid was significantly higher in preeclampsia patients than control (9.22±1.11 mg/dl versus 5.89±.89 mg/dl). HOMA IR was significantly higher in preeclampsia patients then control (4.52±1.68 versus 2.23±1.98).
Conclusions: From present study we can conclude preeclampsia patients were frequent in nulliparous. Preeclampsia is associated with thrombocytopenia. Except increase in AST other hepatic parameters were in normal range and comparable to control. FPG, FPI and HOMA IR were elevated in our finding and it indicates a state of insulin resistance. Preeclampsia patients were also having dyslipidemia. Serum uric acid creatinine and blood urea was significantly higher in preeclampsia patients.
Metrics
References
Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467-74.
Malik A, Jee B, Gupta SK. Preeclampsia: Disease biology and burden, its management strategies with reference to India. Pregnancy Hypertens. 2019;15:23-31.
Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592-4.
Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785-99.
Monte S. Biochemical markers for prediction of preeclampsia: review of the literature. J Prenat Med. 2011;5(3):69-77.
Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circul Res. 2019;124(7):1094-112.
Karar T, Fattah MA, Alenazy KR, Alharbi MJ, Alqahtani FM, Al Tamimi W, et al. Assessment of biochemical changes in pregnancy induced hypertension (PIH) among Saudi population at KAMC-Riyadh. J Adv Med Med Res. 2016:1-6.
Maged AM, Aid G, Bassiouny N, Eldin DS, Dahab S, Ghamry NK. Association of biochemical markers with the severity of pre‐eclampsia. Int J Gynecol Obstet. 2017;136(2):138-44.
Ekun OA, Olawumi OM, Makwe CC, Ogidi NO. Biochemical assessment of renal and liver function among Preeclamptics in Lagos Metropolis. Int J Reprod Med. 2018;2018.
Quan LM, Xu QL, Zhang GQ, Wu LL, Xu H. An analysis of the risk factors of preeclampsia and prediction based on combined biochemical indexes. Kaohsiung J Med Sci. 2018;34(2):109-12.
Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol. 2004;104(6):1367-91.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clinical Chemistry 1972;18(6):499-502
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9.
Dhand NK, Khatkar MS. Statulator: An online statistical calculator. Sample Size Calculator for Comparing Two Independent Means. Available from: http://statulator.com/SampleSize/ss2M.html. Accessed on 28 April 2021.
Lamminpää R, Vehviläinen-Julkunen K, Gissler M, Heinonen S. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997–2008. BMC Pregnancy Childbirth. 2012;12(1):1-5.
Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013;347:f6564.
Motedayen M, Rafiei M, Rezaei Tavirani M, Sayehmiri K, Dousti M. The relationship between body mass index and preeclampsia: a systematic review and meta-analysis. Int J Reprod Biomed. 2019;17(7):463-472.
Lopez-Jaramillo P, Barajas J, Rueda-Quijano SM, Lopez-Lopez C, Felix C. Obesity and preeclampsia: common pathophysiological mechanisms. Front Physiol. 2018;9:1838.
Maeda Y, Kaneko K, Ogawa K, Sago H, Murashima A. The effect of parity, history of preeclampsia, and pregnancy care on the incidence of subsequent preeclampsia in multiparous women with SLE. Mod Rheumatol. 2021;31(4):843-8.
Long PA, Abell DA, Beischer NA. Parity and pre-eclampsia. Aust N Z J Obstet Gynaecol. 1979;19(4):203-6.
Habas E, Rayani A, Ganterie R. Thrombocytopenia in hypertensive disease of pregnancy. J Obstet Gynaecol India. 2013;63(2):96-100.
Heilmann L, Rath W, Pollow K. Hemorheological changes in women with severe preeclampsia. Clin Hemorheol Microcirc. 2004;31(1):49-58.
Munazza B, Raza N, Naureen A, Khan SA, Fatima F, Ayub M, Sulaman M. Liver function tests in preeclampsia. J Ayub Med Coll Abbottabad. 2011;23(4):3-5.
Berkowitz KM. Insulin resistance and preeclampsia. Clin Perinatol. 1998;25(4):873-85.
Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta. 2008;29(Suppl A):S67-72.
Jeyabalan A, Conrad KP. Renal function during normal pregnancy and preeclampsia. Front Biosci. 2007;12:2425-37.
Downloads
Published
How to Cite
Issue
Section
